{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:16:09Z","timestamp":1793088969744,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1001\/jama.2021.11013","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T15:27:03Z","timestamp":1628004423000},"page":"411","source":"Crossref","is-referenced-by-count":262,"title":["Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids"],"prefix":"10.1001","volume":"326","author":[{"given":"Alicia","family":"Agnoli","sequence":"first","affiliation":[{"name":"Department of Family and Community Medicine, University of California, Davis, Sacramento"},{"name":"Center for Healthcare Policy and Research, University of California, Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibo","family":"Xing","sequence":"additional","affiliation":[{"name":"Center for Healthcare Policy and Research, University of California, Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Tancredi","sequence":"additional","affiliation":[{"name":"Center for Healthcare Policy and Research, University of California, Davis, Sacramento"},{"name":"Department of Pediatrics, University of California, Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Magnan","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of California, Davis, Sacramento"},{"name":"Center for Healthcare Policy and Research, University of California, Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Jerant","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of California, Davis, Sacramento"},{"name":"Center for Healthcare Policy and Research, University of California, Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Fenton","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of California, Davis, Sacramento"},{"name":"Center for Healthcare Policy and Research, University of California, Davis, Sacramento"},{"name":"OptumLabs Visiting Fellow, Eden Prairie, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"50-51","key":"joi210076r1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"joi210076r2","doi-asserted-by":"crossref","first-page":"k2833","DOI":"10.1136\/bmj.k2833","article-title":"Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study.","volume":"362","author":"Jeffery","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"joi210076r3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"15","key":"joi210076r4","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"joi210076r5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008-2017.","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"joi210076r6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline.","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"joi210076r7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2017-2018.","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"joi210076r10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jpain.2016.11.003","article-title":"Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial.","volume":"18","author":"Sullivan","year":"2017","journal-title":"J Pain"},{"key":"joi210076r11","doi-asserted-by":"crossref","first-page":"m283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation.","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ"},{"key":"joi210076r12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108248","article-title":"The association between opioid discontinuation and heroin use: a nested case-control study.","volume":"217","author":"Binswanger","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"joi210076r13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","article-title":"Opioid medication discontinuation and risk of adverse opioid-related health care events.","volume":"103","author":"Mark","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"joi210076r14","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s11606-019-05301-2","article-title":"Mortality after discontinuation of primary care-based chronic opioid therapy for pain: a retrospective cohort study.","volume":"34","author":"James","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"10","key":"joi210076r15","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","article-title":"Modeling health benefits and harms of public policy responses to the US opioid epidemic.","volume":"108","author":"Pitt","year":"2018","journal-title":"Am J Public Health"},{"key":"joi210076r16","doi-asserted-by":"crossref","DOI":"10.1093\/pm\/pnaa470","article-title":"Longitudinal dose trajectory among patients tapering long-term opioids.","author":"Fenton","year":"2021","journal-title":"Pain Med"},{"issue":"S1","key":"joi210076r17","doi-asserted-by":"crossref","first-page":"i56","DOI":"10.1136\/injuryprev-2019-043521","article-title":"Defining indicators for drug overdose emergency department visits and hospitalisations in ICD-10-CM coded discharge data.","volume":"27","author":"Vivolo-Kantor","year":"2021","journal-title":"Inj Prev"},{"issue":"5","key":"joi210076r18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/pds.v26.5","article-title":"Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records.","volume":"26","author":"Green","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"joi210076r19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/0033354920904087","article-title":"ICD-10-CM-based definitions for emergency department opioid poisoning surveillance: electronic health record case confirmation study.","volume":"135","author":"Slavova","year":"2020","journal-title":"Public Health Rep"},{"key":"joi210076r20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12888-014-0289-5","article-title":"Systematic review and assessment of validated case definitions for depression in administrative data.","volume":"14","author":"Fiest","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"5","key":"joi210076r21","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/ije\/dyz038","article-title":"A systematic review of validated suicide outcome classification in observational studies.","volume":"48","author":"Swain","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"7","key":"joi210076r24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/MLR.0000000000000735","article-title":"Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser comorbidity index.","volume":"55","author":"Moore","year":"2017","journal-title":"Med Care"},{"issue":"2","key":"joi210076r25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jpain.2018.09.001","article-title":"Patients\u2019 experience with opioid tapering: a conceptual model with recommendations for clinicians.","volume":"20","author":"Henry","year":"2019","journal-title":"J Pain"},{"issue":"10","key":"joi210076r26","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/pm\/pnw078","article-title":"Patients\u2019 perspectives on tapering of chronic opioid therapy: a qualitative study.","volume":"17","author":"Frank","year":"2016","journal-title":"Pain Med"},{"issue":"24","key":"joi210076r27","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing.","volume":"380","author":"Dowell","year":"2019","journal-title":"N Engl J Med"},{"key":"joi210076r28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41394-018-0092-5","article-title":"The drive to taper opioids: mind the evidence, and the ethics.","volume":"4","author":"Kertesz","year":"2018","journal-title":"Spinal Cord Ser Cases"},{"issue":"2","key":"joi210076r29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/08897077.2017.1381663","article-title":"The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary.","volume":"39","author":"Manhapra","year":"2018","journal-title":"Subst Abus"},{"issue":"3","key":"joi210076r30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/j.pain.0000000000000796","article-title":"Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders.","volume":"158","author":"Lovejoy","year":"2017","journal-title":"Pain"},{"issue":"3","key":"joi210076r31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review.","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"},{"key":"joi210076r32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.genhosppsych.2017.04.011","article-title":"Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users.","volume":"47","author":"Demidenko","year":"2017","journal-title":"Gen Hosp Psychiatry"},{"key":"joi210076r22","volume-title":"Documentation: 2010 Rural-Urban Commuting Area (RUCA) Codes","author":"US Department of Agriculture","year":"2016"},{"key":"joi210076r8","unstructured":"FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. US Food and Drug Administration. Published April 12, 2019. Accessed July 6, 2021. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes"},{"key":"joi210076r9","unstructured":"HHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics. US Dept of Health and Human Services. Published October 2019. Accessed November 1, 2019. https:\/\/www.hhs.gov\/opioids\/sites\/default\/files\/2019-10\/Dosage_Reduction_Discontinuation.pdf"},{"key":"joi210076r23","unstructured":"Chronic conditions data warehouse: condition categories. Centers for Medicare & Medicaid Services; 2019. Accessed January 28, 2019. https:\/\/www.ccwdata.org\/web\/guest\/condition-categories"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2782643\/jama_agnoli_2021_oi_210076_1644868471.8517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:29:21Z","timestamp":1644946161000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2782643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.11013","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,3]]}}}